Therapeutic Group: Cardiovascular Presentation Inospiron 25: Each tablet contains Spironolactone BP 25 mg. Inospiron 100 : Each tablet contains Spironolactone BP 100 mg. Description Spironolactone is a long-acting aldosterone antagonist and potassium-sparing diuretic. It acts primarily through competitive binding of receptors at the aldosterone dependent sodium-potassium exchange site in the distal convoluted renal tubule. Spironolactone […]
Therapeutic Group: Anti Bacterial Presentation Tinobac 2 gm IM Injection: Each vial contains sterile powder of Spectinomycin Hydrochloride USP equivalent to Spectinomycin 2 gm. Description Tinobac Sterile Powder contains Spectinomycin Hydrochloride which is an aminocyclitol antibiotic produced by a species of soil microorganism designated as Streptomyces spectabilis. Microbiology Spectinomycin Hydrochloride is an inhibitor of protein […]
Therapeutic Group: Anti Diabetic Presentation Elpida 200: Each film coated tablet contains Sotagliflozin INN 200 mg Description Sotagliflozin is an orally delivered dual inhibitor of SGLT1 and SGLT2. Sotagliflozin improves glycaemic and metabolic control through dual inhibition – local inhibition of SGLT1 in the gut and systemic SGLT2 inhibition in the proximal renal tubule. Inhibition […]
Therapeutic Group: Oncology Presentation Soracent 200: Each tablet contains Sorafenib Tosylate INN equivalent to Sorafenib 200 mg Description Sorafenib is a kinase inhibitor that decreases tumor cell proliferation in vitro. Sorafenib was shown to inhibit multiple intracellular (CRAF, BRAF, and mutant BRAF) and cell surface kinases (KIT, FLT-3, RET, VEGFR-1, VEGFR-2, VEGFR-3, and PDGFR-ß). Several […]
Therapeutic Group: Anti Viral Presentation Hopetavir: Each tablet contains Sofosbuvir INN 400 mg Description Sofosbuvir is a direct-acting antiviral agent against the hepatitis C virus. It is an inhibitor of the HCV NS5B RNA-dependent RNA polymerase, which is essential for viral replication. Indications Sofosbuvir is indicated for the treatment of chronic hepatitis C (CHC) infection […]
Therapeutic Group: Drugs of Nervous System, Antiepileptic Presentation Valex 200 tablet: Each tablet contains Sodium Valproate BP 200 mg. Valex CR 200 tablet: Each controlled release tablet contains Sodium Valproate 200 mg as Sodium Valproate BP 133.2 mg & Valproic Acid BP 58 mg. Valex CR 300 tablet: Each controlled release tablet contains Sodium Valproate […]
Therapeutic Group: Laxative Presentation Abdolax Tablet: Each tablet contains Sodium Picosulfate BP 10 mg. Abdolax Oral solution: Each 5ml contains Sodium Picosulfate BP 5 mg. Description Sodium Picosulfate is a locally acting laxative from the triarylmethane group. It has a dual action – stimulating the mucosa of both the large intestine causing colonic peristalsis and […]
Therapeutic Group: Bone and Joint Disorder Presentation Hyronate Injection: Each pre-filled syringe contains sterile, non-pyrogenic Sodium Hyaluronate BP 20 mg as solution. Description Sodium Hyaluronate is a viscous solution consisting of a high molecular weight fraction of purified natural sodium hyaluronate in buffered physiological sodium phosphate. It has a pH of 5.5-7.0. Hyaluronic acid is […]
Therapeutic Group: Antibiotic Presentation Fucimax Tablet: Each tablet contains Sodium Fusidate BP 250 mg. Description Sodium Fusidate is a potent anti-staphylococcal agent with unusual ability to penetrate tissue. Bactericidal levels have been assayed in bone and necrotic tissue. Concentrations of 0.03 – 0.12 micrograms/ml inhibit nearly all strains of Staphylococcus aureus. Fusidic acid is active […]
Therapeutic Group: Ophthalmic Presentation Mastguard 4% sterile eye/nasal drops: Each ml contains Sodium Cromoglicate BP 40 mg. Description It contains the active ingredient Sodium Cromoglicate which is a type of medicine used to prevent the symptoms of allergies. Sodium Cromoglicate works by acting on mast cells to prevent them from releasing substances that cause the […]